RASOANAIVO chemosensitizers in malaria therapy

Texte de la première page
Bloomfontein, 24-27th October 2004
Strychnos myrtoides and
chemosensitizers in malaria therapy:
From traditional to clinical trials and
drug development
Philippe Rasoanaivo
Institut Malgache de Recherches Appliquées
Antananarivo, Madagascar
World incidence of malaria
DRUG RESISTANCE
Life cycle
LIVING ORGANISMS
How to overcome drug resistance ?
Optimizing
existing drugs
Leads
Chemosensitizers
1980-1985 :sudden malaria recrudescence
in the Highlands of Madagascar
Strychnos myrtoides
Preliminary investigation of Strychnos myrtoides
1.00
50
In vitro
0.80
In vivo
45
40
35
0.60
30
25
20
0.40
15
10
0.20
5
0
0.00
1
0.00
0.20
0.40
N
0.60
0.80
2
Ac
4
CH3
O
H
N
3
1.00
N
CO2CH3
H
O
Malagashanine
CH3
N
O
CH3 O
CH3
Strychnobrasiline
Rasoanaivo P, Ratsimamanga S, Milijaona R, et al. Planta Medica 1994, 60, 13.
Strychnos diplotricha
Strychnos myrtoides
Strychnos mostueoides
M.-T. Martin P. Rasoanaivo, G. Palazzino, et al. Phytochemistry 1999, 51, 479.
P. Rasoanaivo, G. Palazzino, C. Galeffi and M. Nicoletti. Phytochemistry 2001, 56/8, 863.
Traditional recipe
Clinical trials
Clinical observational study
A. Ramialiarisoa, J. Ranaivoravo, P. Rasoanaivo et al., Révue de Médecine et
Pharmacopée Africaines 1994, 8, 123.
Pre-clinical investigations
Phytochemistry
Pharmacology
Toxicology
Pharmacokinetics
Controlled, double blind randomized clinical trial
One relevant pharmacological result
1.00
Fractional IC50 Malagashanine
0.80
0.60
0.40
0.20
0.00
0.00
0.20
0.40
0.60
0.80
1.00
Fractional IC50 Chloroquine
H. Rafatro, D. Ramanitrahasimbola, P. Rasoanaivo, et al.
Biochemical Pharmacology 2000, 59(9), 1053.
Ankazobe ~ 100 km from Antananarivo
Chloroquine + standardized phytomedicine
versus
Chloroquine
Results of the clinical trial
Adequate clinical response
at D14
Positif
Negative
Parasite clearance
at D14
Positif
Negative
Chloroquine
+
placebo
142
19
124
33
Chloroquine
+
phytomedicine
138
18
125
29
TOTAL
280
37
249
62
13,2%
24.9%
Therapeutic failure
Results of the in vitro susceptibility test
404 blood samples collected
291 positive culture
244 interpretable results
190 sensible isolates
58 middle resistant isolates
4 resistant isolates
Evolution of parasite suceptibility
in the same patient
1.00
IC = 3.18 µg/ml,
At inclusion IC50 = 12.35 µg/ml
90
0.80
After one week
continuous culture
After one month
0.60
IC50 = 2.51 µg/ml
IC90 = 17.28 µg/ml
0.40
IC50 = 2.38 µg/ml
IC90 = 17.97 µg/ml
0.20
0.00
0.00
0.20
0.40
0.60
0.80
1.00
Traditional recipe
Bioactive compounds
Source of inspiration
Drug discovery
Chemosensitizing
Pharmacophore
Malagashanine
Synthetic chemosensitizers
MeO
N
MeO
CN
MeO
N
N
H
Desipramine
N
OMe
Verapamil
Cyproteptadine
CH3
N
H
Naturally-occurring
chemosensitizer
CO2CH3
N
H
Ac
O
Malagashanine
N-phenyl-1,3-diamino-propane unit
CH3
N
CO2CH3
N
Ac
N
O
Malagashanine
Desipramine
N
N
H
N
H
1-phenyl-4-amino unit
NC
CH3
H3CO
N
H3CO
Verapamil
OCH3
OCH3
CH3
N
N
Cyproteptadine
Synthesis of derivatives
X
N
R
X = N, C
Bioorg Med Chem Letters (in preparation)
1,4-diamino unit
N
CH3
CO2CH3
N
H
O
Unifying chemosensitizing pharmacophore
R = Alkyl, Phenyl
S’ = N, Phenyl
R
S
(C)n
S'
S = C, N, Phenyl
P Rasoanaivo, D Ramanitrahasimbola, O. Rakotonandrasana, Ethnopharmacologia 2004 (in press)
One confirmation: the pervilleine series
H3CO
OCH3
OCH3
CH33
N
O
O
OCH3
OCH3
O
O
OCH3
B. Cui, G. L. Silva, D. Chavez, M. You, H.-B. Chai, P. Rasoanaivo, S. M. Lynn, M. O’Neill,
J. A. Lewis, J. M. Besterman, A. Monks, N. R. Farnsworth, G. A. Cordell, J. M. Pezzuto,
A. D. Kinghorn. Journal of Natural Products 2001, 64(12), 1514.
Chemosensitizing pharmacophore and polyamines
NH2
H2N
Putrescine
H2N
N
H
NH2
Spermidine
CH3
NC
H3CO
N
OCH3
Verapamil
H3CO
OCH3
CH3
OCH3
OCH3
N
OCH3
H3CO
O
H3CO
O
O
H2N
O
H
N
N
H
Spermine
OCH3
NH2
Interestingly,
chloroquine has a 1,4-diamino unit
HN
Cl
N
N
Chloroquine
Malagashanine
useful biochemical tool
Hypothesis of a reversible CQ transporter
D. Ramanitrahasimbola, P. Rasoanaivo, H. Vial, Biochem Pharmacol (submitted)
Hemisynthesis
O
N
N
CH3
CH3
8 steps
N
O
CO2CH3
N
CH3
O
CH3
O
N
CH3
N
CH3
CO2CH3
N
CO2CH3
N
O
O
F Trigalo, R Joyeau, VC Pham, JJ Youté, P Rasoanaivo, F Frappier .
Tetrahedron 2004, 65, 5471-74.
In summary:
Ethnomedical knowledge
Bioactive compounds
Leads
Drug development
Phytomedicines
Biochemical tool
Synthesis
New activities
Drug
mechanism
Acknowledgements
Muséum National d’Histoire Naturelle
Università degli Studi di Roma “La Sapienza”
Institut de Chimie des Substances Naturelles
Université de Montpellier 2
University of Cape Town
N
A
P
R
E
C
A
Natural Products and Drug Discovery
August 9-12, 2005
Antananarivo, Madagascar
Strychnos myrtoides and
chemosensitizers in malaria therapy:
From traditional to clinical trials and
drug development
Philippe Rasoanaivo
Institut Malgache de Recherches Appliquées
Antananarivo, Madagascar
World incidence of malaria
DRUG RESISTANCE
Life cycle
LIVING ORGANISMS
How to overcome drug resistance ?
Optimizing
existing drugs
Leads
Chemosensitizers
1980-1985 :sudden malaria recrudescence
in the Highlands of Madagascar
Strychnos myrtoides
Preliminary investigation of Strychnos myrtoides
1.00
50
In vitro
0.80
In vivo
45
40
35
0.60
30
25
20
0.40
15
10
0.20
5
0
0.00
1
0.00
0.20
0.40
N
0.60
0.80
2
Ac
4
CH3
O
H
N
3
1.00
N
CO2CH3
H
O
Malagashanine
CH3
N
O
CH3 O
CH3
Strychnobrasiline
Rasoanaivo P, Ratsimamanga S, Milijaona R, et al. Planta Medica 1994, 60, 13.
Strychnos diplotricha
Strychnos myrtoides
Strychnos mostueoides
M.-T. Martin P. Rasoanaivo, G. Palazzino, et al. Phytochemistry 1999, 51, 479.
P. Rasoanaivo, G. Palazzino, C. Galeffi and M. Nicoletti. Phytochemistry 2001, 56/8, 863.
Traditional recipe
Clinical trials
Clinical observational study
A. Ramialiarisoa, J. Ranaivoravo, P. Rasoanaivo et al., Révue de Médecine et
Pharmacopée Africaines 1994, 8, 123.
Pre-clinical investigations
Phytochemistry
Pharmacology
Toxicology
Pharmacokinetics
Controlled, double blind randomized clinical trial
One relevant pharmacological result
1.00
Fractional IC50 Malagashanine
0.80
0.60
0.40
0.20
0.00
0.00
0.20
0.40
0.60
0.80
1.00
Fractional IC50 Chloroquine
H. Rafatro, D. Ramanitrahasimbola, P. Rasoanaivo, et al.
Biochemical Pharmacology 2000, 59(9), 1053.
Ankazobe ~ 100 km from Antananarivo
Chloroquine + standardized phytomedicine
versus
Chloroquine
Results of the clinical trial
Adequate clinical response
at D14
Positif
Negative
Parasite clearance
at D14
Positif
Negative
Chloroquine
+
placebo
142
19
124
33
Chloroquine
+
phytomedicine
138
18
125
29
TOTAL
280
37
249
62
13,2%
24.9%
Therapeutic failure
Results of the in vitro susceptibility test
404 blood samples collected
291 positive culture
244 interpretable results
190 sensible isolates
58 middle resistant isolates
4 resistant isolates
Evolution of parasite suceptibility
in the same patient
1.00
IC = 3.18 µg/ml,
At inclusion IC50 = 12.35 µg/ml
90
0.80
After one week
continuous culture
After one month
0.60
IC50 = 2.51 µg/ml
IC90 = 17.28 µg/ml
0.40
IC50 = 2.38 µg/ml
IC90 = 17.97 µg/ml
0.20
0.00
0.00
0.20
0.40
0.60
0.80
1.00
Traditional recipe
Bioactive compounds
Source of inspiration
Drug discovery
Chemosensitizing
Pharmacophore
Malagashanine
Synthetic chemosensitizers
MeO
N
MeO
CN
MeO
N
N
H
Desipramine
N
OMe
Verapamil
Cyproteptadine
CH3
N
H
Naturally-occurring
chemosensitizer
CO2CH3
N
H
Ac
O
Malagashanine
N-phenyl-1,3-diamino-propane unit
CH3
N
CO2CH3
N
Ac
N
O
Malagashanine
Desipramine
N
N
H
N
H
1-phenyl-4-amino unit
NC
CH3
H3CO
N
H3CO
Verapamil
OCH3
OCH3
CH3
N
N
Cyproteptadine
Synthesis of derivatives
X
N
R
X = N, C
Bioorg Med Chem Letters (in preparation)
1,4-diamino unit
N
CH3
CO2CH3
N
H
O
Unifying chemosensitizing pharmacophore
R = Alkyl, Phenyl
S’ = N, Phenyl
R
S
(C)n
S'
S = C, N, Phenyl
P Rasoanaivo, D Ramanitrahasimbola, O. Rakotonandrasana, Ethnopharmacologia 2004 (in press)
One confirmation: the pervilleine series
H3CO
OCH3
OCH3
CH33
N
O
O
OCH3
OCH3
O
O
OCH3
B. Cui, G. L. Silva, D. Chavez, M. You, H.-B. Chai, P. Rasoanaivo, S. M. Lynn, M. O’Neill,
J. A. Lewis, J. M. Besterman, A. Monks, N. R. Farnsworth, G. A. Cordell, J. M. Pezzuto,
A. D. Kinghorn. Journal of Natural Products 2001, 64(12), 1514.
Chemosensitizing pharmacophore and polyamines
NH2
H2N
Putrescine
H2N
N
H
NH2
Spermidine
CH3
NC
H3CO
N
OCH3
Verapamil
H3CO
OCH3
CH3
OCH3
OCH3
N
OCH3
H3CO
O
H3CO
O
O
H2N
O
H
N
N
H
Spermine
OCH3
NH2
Interestingly,
chloroquine has a 1,4-diamino unit
HN
Cl
N
N
Chloroquine
Malagashanine
useful biochemical tool
Hypothesis of a reversible CQ transporter
D. Ramanitrahasimbola, P. Rasoanaivo, H. Vial, Biochem Pharmacol (submitted)
Hemisynthesis
O
N
N
CH3
CH3
8 steps
N
O
CO2CH3
N
CH3
O
CH3
O
N
CH3
N
CH3
CO2CH3
N
CO2CH3
N
O
O
F Trigalo, R Joyeau, VC Pham, JJ Youté, P Rasoanaivo, F Frappier .
Tetrahedron 2004, 65, 5471-74.
In summary:
Ethnomedical knowledge
Bioactive compounds
Leads
Drug development
Phytomedicines
Biochemical tool
Synthesis
New activities
Drug
mechanism
Acknowledgements
Muséum National d’Histoire Naturelle
Università degli Studi di Roma “La Sapienza”
Institut de Chimie des Substances Naturelles
Université de Montpellier 2
University of Cape Town
N
A
P
R
E
C
A
Natural Products and Drug Discovery
August 9-12, 2005
Antananarivo, Madagascar
Partager ce document
Télécharger le fichier

Faire un lien vers ce document
Lien permanentpour un message, un forum, un réseau social
Lien courtpour un SMS ou un profil
Code HTMLpour un site ou un blog
Du même auteur
- Rasoanaivo Phragmalin limonoids from Neobeguea14/09/2015
- RASOANAIVO biodiversité de Madagascar26/11/2014
- RASOANAIVO espect economique26/11/2014
- RASOANAIVO limites de la chimiothérapie antipalustre26/11/2014
- RASOANAIVO biodiversité dans tous ses etats26/11/2014
- RASOANAIVO Substances Naturelles d’Intérêt Biologique26/11/2014
- RASOANAIVO Plantes medicinales et aromatiques26/11/2014
- RASOANAIVO Plantes Médicinales et SIDA26/11/2014
Voir les autres documents de cet auteur
- RASOANAIVO Organic synthesis26/11/2014
- RASOANAIVO Drug bio-discovery, invention and business26/11/2014
- RASOANAIVO Natural products drug discovery26/11/2014
- RASOANAIVO chromophore reversant26/11/2014
- RASOANAIVO Biodiversité26/11/2014
- RASOANAIVO Biodiversity & Health26/11/2014
- RASOANAIVO Accès aux soins26/11/2014
- RASOANAIVO South-North Collaborative work26/11/2014
- RASOANAIVO Pratiques soignantes, éthique et sociétés26/11/2014
- RASOANAIVO Bioactive compounds to antimalarial plants26/11/2014
- RASOANAIVO Avancer la Santé avec la MT26/11/2014
- RASOANAIVO AMPS-related activities in Madagascar26/11/2014
Sur le même sujet
Les mots qui reviennent le plus dans ce document. Chacun lance une recherche dans les fichiers publics.
Commentaires
Pour voir les commentaires déjà publiés ou ajouter un commentaire, Connectez-vous ou Créez un compte.





